Literature DB >> 32766701

Florid aortitis following SARS-CoV-2 infection.

Simran Shergill1, James Davies1, James Bloomfield1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32766701      PMCID: PMC7454650          DOI: 10.1093/eurheartj/ehaa635

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
A 71-year-old male developed symptoms of a dry cough, fever, diarrhoea, and dyspnoea on 15 March 2020. These resolved after 2 weeks, but an altered taste perception persisted. He later experienced extreme fatigue, poor appetite with 5 kg weight loss, and a sharp left-sided chest pain radiating to his scapula. Computed tomography (CT) thorax, abdomen, and pelvis on 15 May demonstrated a diffuse inflammatory aortitis from the subclavian arteries to the iliac bifurcation, without dissection or pseudoaneurysm formation (Panels A and B; Supplementary material online, Video 1). There was no associated rash, jaw claudication, or joint involvement. Examination revealed normal peripheral pulses without radio-radial delay, subclavian or carotid bruits, and non-tender and pulsatile temporal arteries. Blood profile demonstrated a microcytic anaemia with haemoglobin of 77 g/L, C-reactive protein of 185 mg/L, and interleukin-6 of 28 ng/L. Vasculitic autoantibodies were unremarkable, including a negative syphilis serology and immunoglobulin G (IgG) subclass 4. Transthoracic echocardiogram was normal, with no aortic regurgitation or root dilatation. Temporal artery ultrasound demonstrated clear vessels without inflammation. Nasopharygeal swab was negative for SARS-CoV-2 but positive IgG antibody serology proved recent infection. Prednisolone 40 mg was commenced, and surveillance bloods demonstrated resolution of the anaemia and inflammatory indices. The patient’s symptoms resolved, with return to baseline functioning 2 weeks later. Interval CT angiogram demonstrated partial resolution with a reduction in the circumferential aortitis (Panel C; Supplementary material online, Video 2). Whilst the vasculitic sequelae of SARS-CoV-2 have been well documented in the paediatric population, this is to our knowledge the first reported case of adult aortitis attributed to the COVID-19 pandemic.

Conflict of interest: The authors have submitted their declaration which can be found in the article Supplementary material online. Supplementary material is available at European Heat Journal online Click here for additional data file.
  7 in total

1.  Aortitis in COVID-19.

Authors:  Pravash Dhakal; Sushmita Khadka; Jackie A Clowes; Raja Chandra Chakinala
Journal:  IDCases       Date:  2021-03-10

Review 2.  Aortic Pathology During COVID - 19 Pandemics. Clinical Reports in Literature and Open Questions on the two Co-Occurring Conditions.

Authors:  Valeria Silvestri; Gregorio Egidio Recchia
Journal:  Ann Vasc Surg       Date:  2021-04-03       Impact factor: 1.466

Review 3.  Mimickers of Large Vessel Giant Cell Arteritis.

Authors:  André Ramon; Hélène Greigert; Paul Ornetti; Bernard Bonnotte; Maxime Samson
Journal:  J Clin Med       Date:  2022-01-19       Impact factor: 4.241

Review 4.  COVID-19 Aortitis: A Review of Published Cases.

Authors:  Falah Abu Hassan; Minas Abu Alhalawa; Yacoub Majdoubeh; Ashish Nepal; Sareen S Sufan
Journal:  Cureus       Date:  2022-02-15

Review 5.  Effects of SARS-CoV-2 Inflammation on Selected Organ Systems of the Human Body.

Authors:  Marta Kopańska; Edyta Barnaś; Joanna Błajda; Barbara Kuduk; Anna Łagowska; Agnieszka Banaś-Ząbczyk
Journal:  Int J Mol Sci       Date:  2022-04-10       Impact factor: 6.208

Review 6.  New Onset of Autoimmune Diseases Following COVID-19 Diagnosis.

Authors:  Abraham Edgar Gracia-Ramos; Eduardo Martin-Nares; Gabriela Hernández-Molina
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600

7.  Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report.

Authors:  Edoardo Conticini; Miriana d'Alessandro; Laura Bergantini; Elena Bargagli; Francesco Gentili; Maria Antonietta Mazzei; Luca Cantarini; Bruno Frediani
Journal:  J Med Virol       Date:  2021-07-20       Impact factor: 20.693

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.